If there is any information that you would like included on this page please contact Alexandra Fullem (alexfullem@gmail.com). The website is updated approximately twice a month.
PDP Press Releases/ statements
• 1 Dec: IAVI Statement on World AIDS Day
• 4 Dec: Fierce optimism despite challenging circumstances
• 3 Dec: Quantifying 25 years of malaria control impact in Africa
• 9 Dec: Strengthening malaria control through better ITN surveillance
• 11 Dec: Making Medicines Easier to Take: XTEMP-R Benefits More than Children with TB
• 19 Dec: TB Alliance and Asian Development Bank Forge Strategic Partnership to Strengthen Regional Efforts Against Tuberculosis
• 12 Dec: Staying the course in 2025
• 19 Dec: The appeal of a dual-parasite combination vaccine
• 19 Dec: The future looks bright for malaria prevention
• 2 Dec: First procurement of a preventive antimalarial from Swipha, a Nigerian manufacturer
• 4 Dec: WHO launches the 2025 World Malaria Report as pressure from drug resistance grows
• 9 Dec: Opinion: 3 ways AI can support drug innovation and global research equity
• 15 Dec: Co-creating an innovative AI platform to advance global health research
• 24 Nov: A race against time: antimalarial drug resistance
• 4 Dec: Dr Javid Abdelmoneim, Datuk Dr Mahathar bin Abd Wahab, Dr Taruna Madan, Violet Naanyu, and Dr Mario Santos Moreira join the Board of Directors at DNDi
• 8 Dec: DNDi statement on COP30: Advancing health in the climate agenda
• 16 Dec: DNDi 2025 in Review: A message from DNDi Executive Director Dr Luis Pizarro
• 3 Dec: IVI and the Regionalized Vaccine Manufacturing Collaborative sign partnership agreement to advance regional vaccine manufacturing and equity
• 9 Dec: Scientists in Korea to create mRNA vaccine against emerging tick-borne virus in Asia
• 8 Dec: Placental Malaria remains a major threat to mothers and newborns, new EVI study shows
• 10 Dec: Proving the value of malaria vaccines: how case-control studies can guide immunisation strategies
MDGH
PDP Funder News/Announcements
• 1 Dec: Lenacapavir use kicks off in South Africa and Brazil through Unitaid partnership with Wits RHI and Fiocruz. Unitaid
• 3 Dec: With Child Deaths Projected to Rise for the First Time This Century, Gates Foundation Urges Global Leaders to Target Scarce Resources Where They Save the Most Lives. Gates Foundation
• 3 Dec: €147 million available to fund global health research and innovation. EDCTP3
• 4 Dec: A transformative era for global health: Reflections on my journey with Unitaid. Unitaid
• 8 Dec: With Child Deaths Projected to Rise for the First Time in a Century, Gates Foundation and Mohamed Bin Zayed Foundation for Humanity Urge Action as World Faces Critical Turning Point. Gates Foundation
Funder Announcement Archives
• 2014 PDP Funder Announcements
• 2013 PDP Funder Announcements
New PDP Publications
• 25 Apr: Rethinking antibodies for infectious diseases?. IAVI
Other Reports/ Publications
• 4 Nov: More From Less: Optimising Vaccines in a Constrained World. CGD
• 10 Nov: Report: State of disunion: The impact of US funding cuts on global health R&D. Impact for Global Health
• 12 Dec: Partner Report: The Europe and North America Regional Dialogue on Global Health Architecture Reform. Donor Tracker
• 18 Nov: Genetically modified mosquitoes: Technology and access landscape report. Unitaid
• 25 Nov: The 2025 HIV Market Report: The state of the HIV market in low- and middle-income countries. CHAI
• 25 Nov: The changing impact of malaria control in Africa 2000-2025. Malaria Atlas Project
Related Press Releases/ Announcements/Articles
• 1 Dec: The end of malaria. Vox
• 1 Dec: Money Matters: New data on the world’s biggest development philanthropies. Devex
• 1 Dec: Africa is Stuck Between Global Pathogen-Sharing Talks and Conflicting US Bilateral Agreements. Health Policy Watch
• 1 Dec: Progress In Fight Against Malaria, As New Treatment Shows Promise. Forbes
• 1 Dec: 10 groundbreaking advances that grew out of HIV research. Duke University
• 1 Dec: New prevention tools and investment in services essential in the fight against AIDS. WHO
• 1 Dec: How vaccines – and yoghurt – could reduce colonisation with antibiotic-resistant bugs. Gavi
• 1 Dec: Medicines for All Institute develops low-cost process to make HIV-prevention medication. VCU News
• 1 Dec: Spillover in dengue trials. The Lancet Infectious Diseases
• 1 Dec: Spillover in dengue trials – Author's reply. The Lancet Infectious Diseases
• 1 Dec: SA wants to make its own six-monthly HIV prevention jabs by 2027. But there’s a hitch. Bhekisisa
• 1 Dec: Aid cuts have shaken HIV/Aids care to its core – and will mean millions more infections ahead. The Guardian
• 1 Dec: Treatment and prevention of HIV/AIDS: Unfinished business. PLOS Medicine
• 1 Dec: Lenacapavir Can Transform HIV Prevention—If Countries Support Access. Think Global Health
• 1 Dec: Efficacy and safety of a mosaic HIV-1 vaccine regimen in men who have sex with men and transgender individuals (HVTN 706/HPX3002/Mosaico): a global, randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet HIV
• 2 Dec: Global HIV prevention is not on track: how a health systems approach can promote sustainable progress in African countries. The Lancet HIV
• 2 Dec: Strengthening nationally led approaches to new product introduction for HIV prevention. The Lancet HIV
• 2 Dec: Aligning drug prices and innovation: How global spillovers shape the future of medicines. Vox EU
• 2 Dec: Snare of Bilateral Deals Hangs Over The Multilateral Effort On The Pathogen Access & Benefit Sharing System. Geneva Health Files
• 2 Dec: ‘Creeping catastrophe’: Climate change is driving global rise in infectious diseases, leading health experts warn. Centre for Tropical Medicine and Global Health
• 2 Dec: SA’s first batch of LEN jabs will arrive in February. Use our dashboard to find out who should get them. Bhekisisa
• 3 Dec: Uptake of dapivirine vaginal ring and oral pre-exposure prophylaxis among women accessing HIV prevention services in South Africa: a cohort study. The Lancet HIV
• 3 Dec: Congo hosts Africa’s first simulation exercise on antimicrobial resistance surveillance. WHO AFRO
• 3 Dec: Africa sets course for affordable, quality medicines with new 10-year roadmap. WHO AFRO
• 4 Dec: Global Malaria Threat Deepens as Drug Resistance Rises. Health Policy Watch
• 4 Dec: New tools saved a million lives from malaria last year but progress under threat as drug resistance rises. WHO
• 4 Dec: 200,000 children under the age of 5 to die this year because of foreign aid cuts. The Independent
• 4 Dec: Source of Lenacapavir for PrEP Supply to Early Adopter Countries. AVAC
• 4 Dec: Battle against malaria has stalled, WHO warns. The Telegraph
• 4 Dec: Reimagining global health architecture: the way forward to ensure global health security. The Lancet
• 4 Dec: Health data science revolution in Africa: potential for addressing the myriad health challenges. Nature
• 4 Dec: Zambia rolls out the malaria vaccine – and not a moment too soon. Gavi
• 4 Dec: Beyond Thimerosal: Preserving Vaccine Access Amid Growing Hesitation. Think Global Health
• 4 Dec: A new era dawns for Gavi, as Board underlines strategic shift towards country ownership and increased support for the most vulnerable. Gavi
• 4 Dec: Single-dose dengue vaccine ‘will help Amazon communities’. Gavi
• 4 Dec: Long-acting HIV treatment could improve outcomes for breastfeeding women. News Medical
• 4 Dec: FDA to lower number of trials required for approval of drugs, other medical products. STAT
• 4 Dec: Korea steps up pandemic response with $18.9m investment in CEPI. CEPI
• 4 Dec: US Signs pact with Kenya under America First global health plan. Reuters
• 4 Dec: Pathogens, Power and the Price of Aid: Why Africa Must Stand United. Global Policy Journal
• 4 Dec: Infection Prevention and Control Falters Post-Pandemic – Increasing AMR Risks. Health Policy Watch
• 4 Dec: Foreign aid cuts will see extra 200,000 children under five die this year, damning Gates report warns. The Independent
• 5 Dec: Collaboration Across Africa is Key to Increasing Clinical Trials. Health Policy Watch
• 5 Dec: 7 things you need to know about the state of malaria today. Gavi
• 5 Dec: In Kenya, smaller vaccine vials may mean more children protected. Gavi
• 5 Dec: Gavi Cuts Staff and Support to WHO and UNICEF – Gives More Freedom to Countries to Decide Vaccine Priorities. Health Policy Watch
• 5 Dec: Sabin Vaccine Institute’s Investigational Marburg Vaccine Delivered to Ethiopia for Outbreak Response. BioSpace
• 5 Dec: Countries to reconvene sooner to accelerate progress on WHO Pathogen Access and Benefit Sharing system negotiations. WHO
• 6 Nov: IAVI’s Lassa fever vaccine shows promise in early clinical trials. CEPI
• 6 Dec: US signs $228 mln deal with Rwanda for health under new aid model. Retuers
• 6 Dec: Gavi and World Bank Launch US$2B Partnership to Boost Immunization and Health Systems. Devidiscourse
• 7 Nov: B cells targeting parasites capture spatially linked antigens to secure T cell help. Science
• 7 Nov: American Barter: Aid In Exchange for Information on Pathogen. Geneva Health Files
• 7 Nov: "Relief" for mothers in Bayelsa state as malaria vaccine makes waves. Gavi
• 7 Nov: ‘Africa could be at a turning point in the fight against malaria’. Channel Africa
• 7 Nov: New study evaluates accuracy of rapid diagnostic tests for malaria. Centre for Tropical Medicine & Global Health
• 8 Dec: Global Health Innovative Technology Fund invests ¥70M in molecular mpox test. 360Dx
• 8 Dec: Scientists in Korea to create mRNA vaccine against emerging Asian tick-borne virus. CEPI
• 8 Dec: Kenya limits US access to disease outbreak data in new bilateral deal. Devex
• 8 Dec: Chikungunya adolescent vaccination and the distinct risk–benefit landscapes. The Lancet Infectious Diseases
• 8 Dec: Transitioning to people-centred antimicrobial resistance surveillance. The Lancet Infectious Diseases
• 8 Dec: Safety and immunogenicity of a live-attenuated chikungunya virus vaccine in adolescents: final results from a 12-month, double-blind, randomised, placebo-controlled, phase 3 trial in endemic areas of Brazil. The Lancet Infectious Diseases
• 8 Dec: US-Africa Bilateral Deals Steam Ahead as WHO Struggles to Finalise Global Pathogen Agreement. Health Policy Watch
• 8 Dec: First volunteer receives Lassa Fever vaccine in cutting-edge Oxford trial. University of Oxford
• 8 Dec: Developing Countries Push for Contractual Obligations for Pathogen Access & Benefit Sharing, As Africa-America Realpolitik Gathers Steam With Bilateral Deals. Geneva Health Files
• 9 Dec: On-Demand Dosing of HIV Preexposure Prophylaxis for Women: Has Their Time Finally Come?. The Journal of Infectious Diseases
• 9 Dec: 3 ways AI can support drug innovation and global research equity. Devex
• 9 Dec: How the Foundation is driving real progress toward global health equity. Access to Medicines Foundation
• 9 Dec: University of Oxford launches world’s first Phase II Nipah virus vaccine trial. CEPI
• 9 Dec: The 2024–2025 upsurge of mpox in Africa: another opportunity to accelerate global solidarity for a neglected disease. BMJ
• 9 Dec: Global Consortium Launched to Develop Next-Generation Malaria Vaccine. KEMRI-Wellcome
• 10 Dec: Imperial-led project brings gene-drive mosquitoes closer to reality in Africa. Imperial College London
• 10 Dec: Vaccines fall short in the countries that need them most: HypoVax Global aims to close the gap. LUMC
• 10 Dec: Top funders for malaria-related research and development globally. The Star
• 10 Dec: Mosquitoes outsmarting sprays, WHO report shows. Daily Nation
• 10 Dec: The fight to beat neglected tropical diseases was going well. 2025 could change that. NPR
• 10 Dec: Genetically engineered mosquitoes block development of circulating malaria strains. Nature
• 10 Dec: WHO and the European Commission expand partnership to combat antimicrobial resistance. WHO
• 10 Dec: Major milestone in development of Nipah virus vaccine. The Telegraph
• 10 Dec: FDA approves US-manufactured antibiotic under new priority review program. CIDRAP
• 10 Dec: Sinergium paves the way for Latin American mRNA vaccines with new preclinical study. CEPI
• 10 Dec: UNAIDS calls on African leaders to resource the HIV response, protect human rights, and seize the opportunity of new innovations to end AIDS. UNAIDS
• 11 Dec: Track the Science; Advance the Priorities: The 2025 Update of the People’s Research Agenda. AVAC
• 11 Dec: When politics Trumps science: Why the US isn’t giving SA LEN. Bhekisisa
• 11 Dec: Molecular epidemiology of Plasmodium falciparum drug resistance and vaccine targets in high-transmission settings in Africa. Nature
• 11 Dec: From promise to programs—How to ensure PrEP science is translated into global impact. Positively Aware
• 11 Dec: Zoliflodacin shows benefit as an oral treatment for uncomplicated gonorrhoea. The Lancet
• 11 Dec: New antibiotic can effectively treat gonorrhea, study finds. STAT
• 11 Dec: Global tuberculosis response off track: urgent priorities to end the world's top infectious killer. The Lancet
• 11 Dec: Prevention Intention: Wafaa El-Sadr on People and Persistence in HIV Research. CSIS
• 11 Dec: Africa CDC and Zipline Partner to Advance Health System Responsiveness and Epidemic Preparedness Across Africa. Africa CDC
• 11 Dec: Global Leaders Announce Independent Coalition to Reimagine the Future of Development Cooperation. Future of Development Cooperation
• 11 Dec: Scientists dream of beating malaria by editing disease-carrying mosquitoes' DNA. Could it work?. EuroNews
• 12 Dec: American Science, Shattered. STAT
• 12 Dec: The innovation development and access pathway: A holistic approach to accelerating access to innovative medicines and vaccines. IFPMA
• 12 Dec: FDA approves first new kind of drug to target gonorrhea in decades. STAT
• 12 Dec: The pain after the bite: Tracking Chikungunya’s debilitating impact in East Africa. CEPI
• 12 Dec: New CARB-X awards focus on novel diagnostics for respiratory infections. CIDkRAP
• 12 Dec: The Kenya-US health deal is pragmatic, but could have been done better. Devex
• 12 Dec: As US exit looms, WHO chief defends job cuts and scientific independence. Geneva Solutions
• 12 Nov: WHO cites progress against TB globally but warns about reduced funding. CIDRAP
• 12 Nov: South Africa making first new cholera vaccine in decades. The Telegraph
• 13 Nov: New malaria treatment could fight growing threat of drug resistance. EuroNews
• 13 Nov: US has begun bilateral health negotiations with 16 African nations. Devex
• 13 Nov: Prequalifying the Qualified: The Lenacapavir Paradox. IHP
• 13 Nov: AMR is not just a medical crisis: It an ecological and governance crisis. IHP
• 13 Nov: Rift Valley fever vaccine safe, immune-producing in adults, early-stage trial shows. CIDRAP
• 13 Nov: Gilead hails phase 3 victory for single-tablet combo of bictegravir and lenacapavir, preps filings. Fierce Pharma
• 13 Nov: Weathering the Donor Downturn: The Case for a New Financial Model for the Global Fund. CGD
• 13 Nov: COP30 report reveals how climate change is spreading infectious diseases to new regions. The Conversation
• 13 Nov: AI to tailor malaria and TB drugs to Africa; fungus that lures mosquitoes; and how to address nutrition deficits on the continent. Nature
• 14 Nov: Safety outcomes among infants whose mothers used the dapivirine vaginal ring or oral PrEP during pregnancy (MTN-042/DELIVER): a randomised phase 3b study. The Lancet HIV
• 14 Nov: Single-dose malaria treatment as effective as multi-dose regimen, trial shows. CIDRAP
• 14 Nov: Denmark to cut IAVI funds, prioritizing multilaterals over smaller grants. Devex
• 15 Dec: A year in review: The global health innovation stories that shaped 2025. GHTC
• 15 Dec: Ethiopia’s first R21 malaria vaccine rollout, a global first in a refugee camp. MSF
• 15 Dec: Attivare Therapeutics Awarded $6.6 Million Grant to Advance Durable Malaria Vaccine. BioSpace
• 15 Dec: From Forest to Factory: Tracing the Supply Chains for Two Modern Adjuvants of Global Health Importance — QS-21 and MPL. TAG
• 15 Dec: 2025: A roller-coaster year for global health. World Health Summit
• 16 Dec: New antibiotics hailed as ‘turning point’ in treating drug-resistant gonorrhoea. The Guardian
• 16 Dec: Countries adopt political declaration on diseases despite US pushback. Devex
• 16 Dec: First efficacy evidence for a multistage malaria vaccine targeting infection and transmission. The Lancet
• 16 Dec: Efficacy of ProC6C-AlOH/Matrix-M against Plasmodium falciparum infection and mosquito transmission: a phase 2, randomised, controlled human malaria infection study. The Lancet
• 16 Dec: The Trump Administration’s Epochal Shift on Foreign Aid. Foreign Policy
• 17 Dec: New gonorrhea drug is not just a scientific breakthrough but a business one. STAT
• 17 Dec: Antimalarial drug candidate shows potential for fighting resistance and reducing malaria transmission. MedicalXpress
• 17 Dec: Why I volunteered to be infected with dengue fever. NPR
• 17 Dec: The Unfinished Agenda on Diversifying Vaccine Manufacturing: Six Takeaways from CGD Research. CGD
• 18 Dec: Scientists develop early-warning tool to detect Buruli ulcer hotspots before human cases occur. Doherty Institute
• 18 Dec: Ants show new promise as a source of powerful antibiotics. News Medical
• 18 Dec: What We Know—and Don’t Know—About the Trump Administration’s Global Health Agreements. CGD
• 18 Dec: US–Africa bilateral health deals won’t help against diseases that ignore borders. Nature
• 18 Dec: The Kenya-US Health Agreement: The politics of health data demand scrutiny. University of Oslo
• 18 Dec: EU global health initiative still a mystery months after von der Leyen’s announcement. EuroActiv
• 18 Nov: Recommendations to mitigate barriers to uptake and delivery of a four-dose malaria vaccine schedule: insights from the MVIP’s qualitative evidence. Malaria Journal
• 18 Nov: mRNA delivery of circumsporozoite protein epitope-based malaria vaccines induces protection in a mouse model. Nature
• 18 Nov: Innovation meets impact: Fighting malaria in a warming world. Devex
• 18 Nov: EXCLUSIVE: WHO Cutting Up to 25% of Staff by June 2026 – But ‘Shadow Workforce of Consultants’ Is Unreported. Health Policy Watch
• 18 Nov: The Malaria Vaccine Brings New Hope to Children and Caregivers in Zambia. Unicef
• 18 Nov: Trump administration touts moves to provide HIV prevention drug, but refuses to include South Africa. STAT
• 18 Nov: A 'breakthrough' drug to prevent HIV, an 'unprecedented' rollout. NPR
• 18 Nov: Trump Takes Credit for Lenacapavir Deal after His Administration Decimated U.S. International AIDS Prevention Programs. Public Citizen
• 18 Nov: US health strategy aims to position African governments as customers. Devex
• 18 Nov: How One Vaccine Could Help Fight Drug-Resistant Infections. Foreign Policy
• 19 Dec: I’m the former head of Pfizer R&D. I’m very worried about biopharma’s future. STAT
• 19 Dec: A Plasmodium-derived nanoparticle vaccine elicits sterile protection against malaria in mice. Nature
• 19 Dec: Experimental multistage malaria vaccine shows promising protection in small trial. CIDRAP
• 19 Dec: WHO, WIPO, WTO Symposium Examines Innovation Gaps, Access Inequities, and Supply Challenges in addressing AMR. WIPO
• 19 Dec: The year ahead: What’s next for financing for development and international financial architecture reform in 2026?. Global Policy Forum
• 19 Nov: Global south's TB diagnostics innovations are key to fight the epidemic. Devex
• 19 Nov: As novel approaches drive TB testing expansion, global goal of disease eradication remains elusive. 360Dx
• 19 Nov: The future of global health is at stake. These 7 pioneers could revolutionize it. Vox
• 19 Nov: Researchers develop new method to combat antibiotic-resistant bacteria using bacteriophages. News Medical
• 19 Nov: New drug could be a breakthrough in treatment for killer TB, trial suggests. The Guardian
• 20 Nov: AI and citizens detect invasive mosquito in Madagascar. Gavi
• 20 Nov: Neglecting infectious diseases is a market failure. Financial Times
• 20 Nov: SA Calls for Unified African Action to Build Sustainable Vaccine Manufacturing. DeviDiscourse
• 20 Nov: Ethiopia battles first-ever Marburg outbreak. Gavi
• 20 Nov: A blueprint for access at the heart of outbreak R&D. CEPI
• 20 Nov: UK initiative to explore using AI to address antimicrobial resistance. CIDRAP
• 20 Nov: “We need to be intentional”: five voices on disability inclusive health research in Uganda. The London School of Tropical Medicine and Hygiene
• 20 Nov: South Africa is urged by advocates to issue a compulsory license for Gilead’s HIV prevention drug. STAT
• 20 Nov: Global Fund Seeks $14 Billion at Replenishment Summit – With Progress Against HIV, TB and Malaria at Risk. Health Policy Watch
• 20 Nov: Fundraising summit for Aids, TB and malaria expected to fall billions of pounds short. The Telegraph
• 21 Dec: WHO publishes new global analysis revealing major equity gaps in human genomics research. WHO
• 21 Nov: Common bacterial infections becoming increasingly untreatable, WHO warns. Gavi
• 21 Nov: Global Fund raised $11.34 billion with a surprising US pledge. Devex
• 21 Nov: First look: Full Text of America First Global Health Strategy Specimen Sharing Agreement. Emily Bass
• 22 Dec: The Malaria Vaccine Deal That Could Save Millions — Here’s What to Know. Global Citizen
• 22 Dec: 30 Years of Standing for Science and Equity. AVAC
• 22 Dec: The vaccine cold chain: A fragile link in global health infrastructure. Open Access Government
• 22 Dec: Reducing antibiotic exposure to combat antimicrobial resistance: rethinking use, packaging, and dispensing practices. The Lancet
• 22 Dec: The America First Global Health Strategy and the Dilemma of Pan-Africanism. Global Policy
• 22 Dec: Five big global health wins in 2025 that will save millions of lives. The Guardian
• 22 Dec: Where did the Gates Foundation spend its money?. Devex
• 23 Dec: Equitable access to essential medicines to treat neglected tropical diseases: Latest developments from the World Health Organization. PLOS
• 23 Dec: Why NTDs are a prime investment for philanthropy. Devex
• 23 Dec: Why Is a 100-Year-Old Vaccine Still Our Only Defense Against the World’s Deadliest Infectious Disease?. Global Citizen
• 23 Dec: Meet Dr Happi. With $100m and a steely determination could he save the world from the next pandemic?. The Guardian
• 23 Dec: Japan to join Horizon Europe, strengthening EU role in global science. Science Business
• 24 Dec: US signs health agreements with African nations, warns against nonperformance. Reuters
• 24 Dec: How drug resistance undermines Africa's malaria milestones. TRT Afrika
• 24 Dec: WHO Finds Progress in Malaria Prevention Measures. Contagion Live
• 24 Nov: Fightback: scientists score series of wins in battle against superbugs. The Telegraph
• 24 Nov: Marburg outbreak worsens in Ethiopia as death toll rises. The Telegraph
• 24 Nov: HIV Prevention R&D at Risk. AVAC
• 24 Nov: To tackle rising antibiotic resistance, GARDP aims for access. CIDRAP
• 24 Nov: New vapor tool fights mosquitoes by slowly releasing insecticide in homes. Will it catch on?. Science
• 24 Nov: "The biggest tech transfer program in the history of all medical technology": Petro Terblanche, CEO, Afrigen Biologics And Vaccines on the mRNA Tech Transfer Programme . Geneva Health Files
• 25 Nov: EDCTP: Two decades of Africa-Europe partnership delivering excellent science and life-saving innovations. Science Business
• 25 Nov: New WHO framework aims to tackle rising resistance to HIV, STI, and hepatitis treatments. CIDRAP
• 25 Nov: Antibiotic resistance: how a pioneering trial is using old drugs to save babies from sepsis. The Guardian
• 25 Dec: Integrating mobile laboratories into global health security: advancing collaboration through GOARN-DiSC. BMJ
• 26 Dec: 3 issues to watch in public health in 2026. STAT
• 26 Dec: Bridging the policy gap between climate change and antimicrobial resistance. The Lancet
• 26 Nov: A Turning Point: Lusaka Agenda is Anchored in the G20 Declaration. Health Policy Watch
• 26 Nov: Can AI Democratize the Global Fight Against Malaria?. Health Policy Watch
• 26 Nov: A much-needed vaccine for Nipah virus. Nature
• 26 Nov: Brazil approves world's first single-dose dengue vaccine. France24
• 27 Nov: Breakthrough in Malaria Prevention: New Vaccine and Adjuvant Unveiled. Devidiscourse
• 27 Nov: “Miraculous” HIV drug to be rolled out after overcoming aid cuts threat. BMJ
• 27 Nov: Patronus Biotech receives grant to evaluate a novel malaria vaccine and adjuvant to support affordable access and use in global health. The Korea Herald
• 27 Nov: “Act Now!” Yes, but with what, exactly? On #AMR and the realities of unequal access. IHP
• 27 Nov: What will the Global Development Architecture look like in 2030? And What can the EU and UK do to Influence It?. Global Policy Journal
• 28 Dec: How Cameroon Fought to Save Its Malaria Program After the U.S. Cut Critical Funding. The New York Times
• 28 Dec: 2025: A Brutal Year for Global Health. Health Policy Watch
• 29 Dec: America First Global Health Strategy: What the Kenya-US Agreement reveals about the new politics of global health assistance. LSE
• 29 Dec: The Guardian view on antibiotics: recent breakthroughs are great news, but humanity is losing the bigger race. The Guardian
• 29 Dec: Trump administration agrees to reconsider frozen and denied NIH grant submissions related to DEI. STAT
• 29 Dec: 4 more African nations secure $2.3bn US health funding under America First strategy. Business Insider Africa
• 30 Dec: More than half a million chikungunya cases reported globally in 2025. CIDRAP
• 30 Dec: The Trump Administration’s Most Paralyzing Blow to Science. The Atlantic
• 30 Dec: In a year of steep challenges, there were still shining moments in global health. NPR
• 31 Dec: Health advances marked 2025 as wars and funding cuts strained systems. UN News
Upcoming Meetings/ Webinars
--------------------------